Applied DNA Sciences Inc (APDN)
0.4084
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
0.4097
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Accounts Receivable (Quarterly): 0.4089M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.4089M |
December 31, 2023 | 0.4508M |
September 30, 2023 | 0.2555M |
June 30, 2023 | 0.6827M |
March 31, 2023 | 1.968M |
December 31, 2022 | 4.054M |
September 30, 2022 | 3.068M |
June 30, 2022 | 2.859M |
March 31, 2022 | 2.588M |
December 31, 2021 | 3.857M |
September 30, 2021 | 2.804M |
June 30, 2021 | 0.7373M |
March 31, 2021 | 2.186M |
December 31, 2020 | 1.034M |
September 30, 2020 | 0.1943M |
June 30, 2020 | 0.2312M |
March 31, 2020 | 0.5491M |
December 31, 2019 | 0.274M |
September 30, 2019 | 0.84M |
June 30, 2019 | 0.2436M |
March 31, 2019 | 0.3162M |
December 31, 2018 | 0.6148M |
September 30, 2018 | 1.486M |
June 30, 2018 | 1.415M |
March 31, 2018 | 1.526M |
Date | Value |
---|---|
December 31, 2017 | 2.156M |
September 30, 2017 | 2.588M |
June 30, 2017 | 4.746M |
March 31, 2017 | 5.192M |
December 31, 2016 | 6.156M |
September 30, 2016 | 6.375M |
June 30, 2016 | 4.792M |
March 31, 2016 | 5.027M |
December 31, 2015 | 3.924M |
September 30, 2015 | 3.930M |
June 30, 2015 | 2.078M |
March 31, 2015 | 1.160M |
December 31, 2014 | 1.114M |
September 30, 2014 | 0.8348M |
June 30, 2014 | 0.5183M |
March 31, 2014 | 0.606M |
December 31, 2013 | 0.7494M |
September 30, 2013 | 0.6726M |
June 30, 2013 | 0.5877M |
March 31, 2013 | 0.4078M |
December 31, 2012 | 0.3618M |
September 30, 2012 | 0.297M |
June 30, 2012 | 0.4428M |
March 31, 2012 | 0.3236M |
December 31, 2011 | 0.2326M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.1943M
Minimum
Sep 2020
4.054M
Maximum
Dec 2022
1.464M
Average
0.7886M
Median
Accounts Receivable (Quarterly) Benchmarks
Fonar Corp | 26.92M |
XWELL Inc | 2.90M |
ProPhase Labs Inc | 35.12M |
Veracyte Inc | 46.66M |
OncoCyte Corp | 0.161M |